The Economic Challenge Of Cell Therapy Manufacturing
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics, discusses the economic challenges surrounding cell therapy manufacturing. Joining the conversation are Bryan Butman, Ph.D., head of CMC, Precigen; and Louise Perry, SVP Tech Ops, Solid Biosciences.
This website uses cookies to ensure you get the best experience on our website. Learn more